BENITEC BIOPHARMA INC. (BNTC) Operating cash flow 2019–2026
BENITEC BIOPHARMA INC. (BNTC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$16.5MFY2026 · since FY2019: $4.8M → -$16.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$16.5M | +30.0% |
| FY2025 | -$23.6M | -21.6% |
| FY2024 | -$19.4M | -7.7% |
| FY2023 | -$18.0M | -13.3% |
| FY2022 | -$15.9M | -23.9% |
| FY2021 | -$12.8M | -70.3% |
| FY2020 | -$7.5M | -257.3% |
| FY2019 | $4.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BNTC financial trends
BNTC RevenueBNTC Net incomeBNTC Net marginBNTC Gross profitBNTC Gross marginBNTC Operating incomeBNTC Operating marginBNTC Free cash flowBNTC Capital expendituresBNTC Return on equityBNTC Stock buybacksBNTC Dividends paidBNTC Total assetsBNTC Total liabilitiesBNTC Shareholders’ equityBNTC overview →